Phase I multiple dose-escalation trial investigating the tolerability of DV 1179 in healthy subjects.

Trial Profile

Phase I multiple dose-escalation trial investigating the tolerability of DV 1179 in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Dec 2011

At a glance

  • Drugs DV 1179 (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Dec 2011 Status changed from recruiting to completed.
    • 21 Apr 2011 New trial record
    • 20 Apr 2011 Data are expected later in 2011, according to a Dynavax Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top